Please login to the form below

Not currently logged in
Email:
Password:

Ferring

This page shows the latest Ferring news and features for those working in and with pharma, biotech and healthcare.

FDA green lights study of phage-based drug for resistant infections

FDA green lights study of phage-based drug for resistant infections

Ferring Pharma and Institut Pasteur are also exploring phages to tackle bacteria associated with inflammatory bowel disease.

Latest news

More from news
Approximately 7 fully matching, plus 35 partially matching documents found.

Latest Intelligence

  • Case study: Project Family Case study: Project Family

    The aim was to raise the profile of Ferring with healthcare professionals and potential partners. ... Our new approach to external communications has well and truly put Ferring on everyone’s radar.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    138.5. TxCell/ Ferring. Collaboration, option,  licence. Ovasave - personalised cell-based immunotherapy for IBD (inc Crohn's disease, ulcerative colitis) (p2).

  • Interview: Michel Pettigrew, Ferring Interview: Michel Pettigrew, Ferring

    Single-minded pursuit of progress. So, how does Ferring stand out within the industry? ... As Pettigrew notes, in Ferring's case 'privately owned' really does mean 'privately owned'.

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • McCann Health France strengthens team with two new hires McCann Health France strengthens team with two new hires

    That includes working on products for a number of major pharmaceutical and healthcare companies, including Ferring Pharmaceuticals, Sanofi, Merck, Procter &Gamble and Nestle’s global consumer health segment.

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    Ferring Pharmaceuticals has bolstered its oncology division team, appointing Sophie Opdyke (pictured below) as its vice president, general manager. ... leadership team.”. Opdyke, who has more than 20 years’ experience, joins Ferring from Pfizer,

  • IFPMA names new communications director IFPMA names new communications director

    Helen Gallagher joins the association from Ferring Pharmaceuticals. IFPMA has appointed Helen Gallagher as  its new communications director, a role that will see her act as a key spokesperson for the ... Prior to her new role at IFPMA, Gallagher headed

  • Sobi appoints Torbjorn Hallberg as general counsel Sobi appoints Torbjorn Hallberg as general counsel

    He arrives at Sobi will more than 15 years’ experience covering licensing, mergers and acquisitions at pharma groups such as  Ferring and Nycomed.

  • Ferring appoints executive VP and chief medical officer Ferring appoints executive VP and chief medical officer

    Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim. Ferring Pharmaceuticals has appointed professor Klaus Dugi as its executive vice president and chief medical officer; roles that will see him ... Michel Pettigrew, president of the

More from appointments
Approximately 7 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Visformatics (VISFO)

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...